tirzepatide pregnancy washout period The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome Tirzepatide and Pregnancy: Safety, Risks,

Researchers are currently investigating a new weight loss medication called retatrutide that may have even better weight loss effects than the GLP-1 agonists

Clinical trials have demonstrated that tirzepatide produces substantial improvements in glycemic control, with HbA1c reductions of 1.9% to 2.4% at the highest doses in the SURPASS trials

Clinical trials have documented substantial weight loss with these medicationstypically 15% of body weight with semaglutide 2.4 mg (STEP 1 trial) and approximately 21% with tirzepatide 15 mg (SURMOUNT-1 trial) at 72 weeks

There is no prior authorization, step therapy, or utilization management